|
1 Indications And Usage Emend ® For Oral Suspension, In Combination With Other Antiemetic Agents, Is Indicated In Patients 6 Months Of Age And Older For The Prevention Of: Acute And Delayed Nausea And Vomiting Associated With Initial And Repeat Courses Of Highly Emetogenic Cancer Chemotherapy (Hec) Including High-Dose Cisplatin. Nausea And Vomiting Associated With Initial And Repeat Courses Of Moderately Emetogenic Cancer Chemotherapy (Mec). Emend ® Capsules, In Combination With Other Antiemetic Agents, Is Indicated In Patients 12 Years Of Age And Older For The Prevention Of: Acute And Delayed Nausea And Vomiting Associated With Initial And Repeat Courses Of Highly Emetogenic Cancer Chemotherapy (Hec) Including High-Dose Cisplatin. Nausea And Vomiting Associated With Initial And Repeat Courses Of Moderately Emetogenic Cancer Chemotherapy (Mec). Emend ® Is A Substance P/neurokinin 1 (Nk 1 ) Receptor Antagonist. Emend For Oral Suspension Is Indicated In Combination With Other Antiemetic Agents, In Patients 6 Months Of Age And Older For Prevention Of: Acute And Delayed Nausea And Vomiting Associated With Initial And Repeat Courses Of Highly Emetogenic Cancer Chemotherapy (Hec) Including High-Dose Cisplatin ( 1 ) Nausea And Vomiting Associated With Initial And Repeat Courses Of Moderately Emetogenic Cancer Chemotherapy (Mec) ( 1 ) Emend Capsules Is Indicated In Combination With Other Antiemetic Agents, In Patients 12 Years Of Age And Older For Prevention Of: Acute And Delayed Nausea And Vomiting Associated With Initial And Repeat Courses Of Highly Emetogenic Cancer Chemotherapy (Hec) Including High-Dose Cisplatin ( 1 ) Nausea And Vomiting Associated With Initial And Repeat Courses Of Moderately Emetogenic Cancer Chemotherapy (Mec) ( 1 ) Limitations Of Use ( 1 ) Emend Has Not Been Studied For Treatment Of Established Nausea And Vomiting. Chronic Continuous Administration Of Emend Is Not Recommended. Limitations Of Use Emend Has Not Been Studied For The Treatment Of Established Nausea And Vomiting. Chronic Continuous Administration Of Emend Is Not Recommended Because It Has Not Been Studied, And Because The Drug Interaction Profile May Change During Chronic Continuous Use.
|